scholarly journals A Study on the National Drug Policies of Bangladesh to Ensure Health for All

2021 ◽  
Vol 20 (1) ◽  
pp. 41-48
Author(s):  
Md Aknur Rahman ◽  
Md Riaz Hossain ◽  
Md Aslam Hossain ◽  
Md Shah Amran
Keyword(s):  
Drug Policy ◽  
World Health ◽  
Expert Committee ◽  
Public Servants ◽  
National Drug ◽  
National Drug Policy ◽  
The World ◽  
Drug Policies ◽  
Health Organization ◽  
Almost All

Bangladesh approved the proposal for a National Drug Policy on May 29, 1982. We know that such drug policies are developed gradually over a period of time and may contain a lot of comprehensive documents. But in Bangladesh, the expert committee worked out the policy, based on 16 standards within 15 days. This vital document, almost unchanged, was made a law on 12 June 1982. A few years later, it can be observed that despite opposition from many concerns, the output of essential drugs has increased from about 30 to about 80 percent, prices have in almost all cases gone down considerably, the domestic industry has grown rapidly, the quality of its production has increased dramatically, and people’s awareness about quality medicines has been steadily growing. The World Health Organization (WHO) has stressed the need of a formulated drug policy in every country of the world in 1986. Bangladesh responded very early to this respect. Subsequently, two more national drug policies were promulgated in 2005 and 2016 respectively. Experience over the decades has shown that the said policies could not fulfill the declared objective of ensuring health for all. Our aim is to describe some of the lacunae for which total implementation of drug policy is still struggling. To find the root causes, a total of five hundred volunteers were surveyed by supplying a questionnaire on drug policy. It was observed that most of the participants opined that the incumbent government needs to be more stringent to implement the drug policy into reality by utilizing the public servants and public sectors, especially health personnel to ensure health for all. Dhaka Univ. J. Pharm. Sci. 20(1): 41-48, 2021 (June)

scholarly journals Implementation of National Drug Policy in Different Countries: An Appraisal and Experience from Bangladesh

1970 ◽  
Vol 29 (3) ◽  
pp. 177-179
Author(s):  
FR Chowdhury ◽  
MS Bari ◽  
MI Khan
Keyword(s):  
World Health Organization ◽  
Key Words ◽  
Drug Policy ◽  
World Health ◽  
National Drug ◽  
National Drug Policy ◽  
Health Organization

Key Words: National Drug Policy; World Health Organization; Bangladesh.DOI: http://dx.doi.org/10.3329/jbcps.v29i3.9442 JBCPS 2011; 29(3): 177-179

scholarly journals COVID-19 pandemic: A review of the global lockdown and its far-reaching effects

2021 ◽  
Vol 104 (2) ◽  
pp. 003685042110198
Author(s):  
Helen Onyeaka ◽  
Christian K Anumudu ◽  
Zainab T Al-Sharify ◽  
Esther Egele-Godswill ◽  
Paul Mbaegbu
Keyword(s):  
Mental Health ◽  
Global Economy ◽  
World Health ◽  
Global Pandemic ◽  
The World ◽  
Education Delivery ◽  
Environmental Air ◽  
Health Organization ◽  
Almost All ◽  
The Impact

COVID-19, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was declared a pandemic by the World Health Organization (WHO) on the 11th of March 2020, leading to some form of lockdown across almost all countries of the world. The extent of the global pandemic due to COVID-19 has a significant impact on our lives that must be studied carefully to combat it. This study highlights the impacts of the COVID-19 pandemic lockdown on crucial aspects of daily life globally, including; Food security, Global economy, Education, Tourism, hospitality, sports and leisure, Gender Relation, Domestic Violence/Abuse, Mental Health and Environmental air pollution through a systematic search of the literature. The COVID-19 global lockdown was initiated to stem the spread of the virus and ‘flatten the curve’ of the pandemic. However, the impact of the lockdown has had far-reaching effects in different strata of life, including; changes in the accessibility and structure of education delivery to students, food insecurity as a result of unavailability and fluctuation in prices, the depression of the global economy, increase in mental health challenges, wellbeing and quality of life amongst others. This review article highlights the impacts of the COVID-19 pandemic lockdown across the globe. As the global lockdown is being lifted in a phased manner in various countries of the world, it is necessary to explore its impacts to understand its consequences comprehensively. This will guide future decisions that will be made in a possible future wave of the COVID-19 pandemic or other global disease outbreak.

Health Problems of Adolescence: Report of a WHO Expert Committee. World Health Organization:

PEDIATRICS ◽  
1966 ◽  
Vol 37 (2) ◽  
pp. 392-392
Author(s):  
THOMAS E. CONE
Keyword(s):  
World Health Organization ◽  
Health Problems ◽  
World Health ◽  
Expert Committee ◽  
Age Group ◽  
Committee Meeting ◽  
Adolescent Population ◽  
The World ◽  
Group 15 ◽  
Health Organization

This is a timely, concise, eminently practical, thoughtfully, even tenderly, written 28 page report of a recent WHO Expert Committee meeting on the health problems of adolescence. The members and the consultants to the Committee deftly summarize the major worldwide trends affecting our adolescent population. The size of this population is staggering; in the age group 15-19 years alone there are already 300 million adolescents in the world, and there seems every likelihood that these numbers will increase rapidly during the next decade.

TIRYAQ-E-ARBA (A POLY HERBAL UNANI FORMULATION) IN FIGHTING AGAINST COVID 19 LIKE CONDITIONS – UNANI PERSPECTIVE

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Nafisa Qibriya Khan ◽  
A. H. Farooqui ◽  
Syed Ayesha Fatima ◽  
Jalil Ahmad ◽  
Tausif S. Khan
Keyword(s):  
Respiratory Infections ◽  
Transmission Rate ◽  
Multiple Organ ◽  
World Health ◽  
Upper Respiratory Tract ◽  
Health Crisis ◽  
Unani Medicine ◽  
The World ◽  
Health Organization ◽  
Almost All

Coronavirus disease 2019 (COVID-19) is a pandemic disease of modern time with unique and rapid transmission rate and affected almost all the nations without respecting any border. Coronavirus disease 2019 (COVID-19) is arguably the biggest health crisis the world has faced in 21st century. It is an infectious disease and declared pandemic by the World Health Organization. The coronavirus disease 2019 (COVID-19) outbreak, which originated in Wuhan, China, has now spread to 192 countries and administrative regions infecting nearly 800,000 individuals of all ages as of 31 March 2020. Though most infected individuals exhibit mild symptoms including fever, upper respiratory tract symptoms, shortness of breath, and diarrhoea, or are asymptomatic altogether, severe cases of infection can lead to pneumonia, multiple organ failure, and death. Globally, at least 7900 deaths have been directly attributed to COVID19, and this number is expected to rise with the ongoing epidemic. This is particularly crucial as the current outbreak involves a new pathogen (SARS-CoV-2), on which limited knowledge exists of its infectivity and clinical profile. Research is in progress on therapeutic efficacy of various agents including anti-malarials (Chloroquine and Hydroxychloroquine), antiviral drugs, and convalescent serum of recovered patients. Unani system of medicine is one of the traditional systems of medicine which is being explored for providing preventive, supportive and rehabilitative care to patients. Unani system of medicine has a detailed description of drugs that are utilized in many infectious diseases, including respiratory infections. Immune response is essential to eliminate virus and to preclude disease progression to severe stages. Therefore, it is important to summarize the evidence regarding the preventive measures, control options such as immune-stimulator and prophylactic treatment in Unani medicine against Covid19. This review summarizes various pharmacological actions of Unani formulation Tiryaq-e-Arba in Unani literature and various reported pharmacological activities which can possibly provide prevention, control and reduction of complications of this deadly disease.

PUBLIC HEALTH, NURSING AND MEDICAL SOCIAL WORK

PEDIATRICS ◽  
1953 ◽  
Vol 11 (3) ◽  
pp. 290-293
Keyword(s):  
World Health Organization ◽  
Health Program ◽  
International Health ◽  
World Health ◽  
Expert Committee ◽  
Medical Social Work ◽  
The World ◽  
Health Nursing ◽  
Health Organization ◽  
Sales Agents

STANDARDIZATION of terminology for drugs and scientific substances appears to be a highly desirable goal. Exchange of information through publication and individual communication would be far less subject to misinterpretation if nomenclature were precise and unchanged. Furthermore, increase in world travel makes it more necessary than ever that patients, physicians, and pharmacists be able severally to request and comply with requests for drugs without worry about differences in names. International health co-operation and regional health program would obviously benefit from simplification of terminology. The situation has recently been reviewed by P. Blanc, Secretary of the World Health Organization Expert Committee on the International Pharmacopoeia, before the International Pharmaceutical Federation. His paper has been summarized in the Chronicle of the World Health Organization, for November 1952, volume 6, page 322, from which the following extracts are taken: "At first sight it might seem that, for the numerous drugs which are chemical compounds, the chemical names could be used; but the latter are often so complicated that manufacturers and sales agents spontaneously adopt simpler and shorter names. Obviously `riboflavine' sounds better and is more easily remembered than 6:7-dimethyl-9-(D-1'-ribityl)izo-alloxazine. But, unfortunately, the same substance is known elsewhere by the name of `lactoflavine' or `vitamin B2'. Another example may be cited, namely that of the methadone hydrochloride of the Pharmacopoea Internationalis (6-dimethylamino-4,4-diphenyl-3-heptanone), which is known in different countries under the following names: amidone, miadone, diadone, diaminon, mephenon, symoron, etc.

scholarly journals Barriers and facilitators to adherence to national drug policies on antibiotic prescribing and dispensing in Bangladesh

2021 ◽  
Vol 14 (S1) ◽  
Author(s):  
Fosiul Alam Nizame ◽  
Dewan Muhammad Shoaib ◽  
Emily K. Rousham ◽  
Salma Akter ◽  
Mohammad Aminul Islam ◽  
...  
Keyword(s):  
Drug Policy ◽  
Group Discussion ◽  
National Policy ◽  
Barriers And Facilitators ◽  
Drug Shop ◽  
Antibiotic Prescribing ◽  
National Drug ◽  
National Drug Policy ◽  
Drug Policies ◽  
The Government

Abstract Background The National Drug Policy in Bangladesh prohibits the sale and distribution of antibiotics without prescription from a registered physician. Compliance with this policy is poor; prescribing antibiotics by unqualified practitioners is common and over-the-counter dispensing widespread. In Bangladesh, unqualified practitioners such as drug shop operators are a major source of healthcare for the poor and disadvantaged. This paper reports on policy awareness among drug shop operators and their customers and identifies current dispensing practices, barriers and facilitators to policy adherence. Methods We conducted a qualitative study in rural and urban Bangladesh from June 2019 to August 2020. This included co-design workshops (n = 4) and in-depth interviews (n = 24) with drug shop operators and customers/household members, key informant interviews (n = 12) with key personnel involved in aspects of the antibiotic supply chain including pharmaceutical company representatives, and model drug shop operators; and a group discussion with stakeholders representing key actors in informal market systems namely: representatives from the government, private sector, not-for-profit sector and membership organizations. Results Barriers to policy compliance among drug shop operators included limited knowledge of government drug policies, or the government-led Bangladesh Pharmacy Model Initiative (BPMI), a national guideline piloted to regulate drug sales. Drug shop operators had no clear knowledge of different antibiotic generations, how and for what diseases antibiotics work contributing to inappropriate antibiotic dispensing. Nonetheless, drug shop operators wanted the right to prescribe antibiotics based on having completed related training. Drug shop customers cited poor healthcare facilities and inadequate numbers of attending physician as a barrier to obtaining prescriptions and they described difficulties differentiating between qualified and unqualified providers. Conclusion Awareness of the National Drug Policy and the BPMI was limited among urban and rural drug shop operators. Poor antibiotic prescribing practice is additionally hampered by a shortage of qualified physicians; cultural and economic barriers to accessing qualified physicians, and poor implementation of regulations. Increasing qualified physician access and increasing training and certification of drug shop operators could improve the alignment of practices with national policy.

scholarly journals New Normal: An Hrm Perspective of Post COVID-19 in the Airline Industry

2020 ◽  
Author(s):  
Hassan Imam
Keyword(s):  
Public Health ◽  
Conceptual Understanding ◽  
Airline Industry ◽  
Global Financial Crisis ◽  
Public Health Emergency ◽  
World Health ◽  
The World ◽  
Health Organization ◽  
The Global Financial Crisis ◽  
Almost All

In January 2020, the World Health Organization declared a public health emergency and announced a new coronavirus disease (COVID-19), which would later go on to be declared as a pandemic, changing the global sphere and placing the economies of almost all countries under heavy stress. The airline industry, that had just begun recovering after facing crises one after another in the last two decades, from early 2000 due to 9/11, to the global financial crisis later, is now oce again facing an enormous challenge of closed borders and greater lockdowns due to the pandemic. Borders are closed, with very few planes are in the air, while the rest are grounded. The purpose of this paper is to give a conceptual understanding of the current pandemic situation and its consequences on the airline industry. The paper takes a unique perspective of human resource management (HRM) that is rarely used in the airline industry.

Using COVID19 as an Opportunity to Measure Seismic Silences and Bring Geoscience Projects to Students

2021 ◽  
Author(s):  
Artash Nath
Keyword(s):  
Northwest Territories ◽  
World Health ◽  
Virtual Classrooms ◽  
Power Spectral ◽  
Essential Services ◽  
Power Spectral Densities ◽  
The World ◽  
Seismic Vibrations ◽  
Health Organization ◽  
Almost All

<p>On 11 March 2020, the World Health Organization declared Covid19 a pandemic. Countries around the world rushed to declare various states of emergencies. Canada also implemented emergency measures to restrict the movements of people including the closure of borders, non-essential services, and schools and offices to slow the spread of Covid19. I used this opportunity to measure changes in seismic vibrations registered in Canada before, during, and after the lockdown due to the slowdown in transportation, economic, and construction activities. I analyzed continuous seismic data for 6 Canadian cities: Calgary and Edmonton (Alberta), Montreal (Quebec), Ottawa, and Toronto (Ontario), and Yellowknife (Northwest Territories). These cities represented the wide geographical spread of Canada. The source of data was seismic stations run by the Canadian National Seismograph Network (CNSN). Python and ObSpy libraries were used to convert raw data into probabilistic power spectral densities. The seismic vibrations in the PPSDs that fell between 4 Hz and 20 Hz were extracted and averaged for every two weeks period to determine the trend of seismic vibrations. The lockdown had an impact on seismic vibrations in almost all the cities I analyzed. The seismic vibrations decreased between 14% - 44% with the biggest decrease in Yellowknife in the Northwest Territories. In the 3 densely populated cities with a population of over 1 million - Toronto, Montreal, and Calgary, the vibrations dropped by over 30%.</p><p>To enable other students to undertake similar projects for their cities, I created a comprehensive online training module using Jupyter notebooks available on Github. Students can learn about seismic vibrations, how to obtain datasets, and analyze and interpret them using Python. They can share their findings with local policymakers so that they become aware of the effectiveness of the lockdown imposed and are better prepared for lockdowns in the future. When we make data and technology accessible, then lockdowns because of pandemics can be an opportunity for students to take up practical geoscience projects from home or virtual classrooms.</p>

scholarly journals Is hydroxychloroquine beneficial for COVID-19 patients?

2020 ◽  
Vol 11 (7) ◽  
Author(s):  
Xing Li ◽  
Ying Wang ◽  
Patrizia Agostinis ◽  
Arnold Rabson ◽  
Gerry Melino ◽  
...  
Keyword(s):  
Public Health ◽  
Severe Acute Respiratory Syndrome ◽  
Emergency Care ◽  
Public Health Emergency ◽  
World Health ◽  
Beneficial Effects ◽  
The World ◽  
Health Organization ◽  
Almost All ◽  
Effective Drugs

Abstract The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar cases rapidly emerged around the world1–3, the World Health Organization (WHO) declared a public health emergency of international concern on January 30, 2020 and pronounced the rapidly spreading coronavirus outbreak as a pandemic on March 11, 20204. The virus has reached almost all countries of the globe. As of June 3, 2020, the accumulated confirmed cases reached 6,479,405 with more than 383,013 deaths worldwide. The urgent and emergency care of COVID-19 patients calls for effective drugs, in addition to the beneficial effects of remdesivir5, to control the disease and halt the pandemic.

Recommendations for Establishing a Drug and Toxicology Information Center in a Developing Country

DICP ◽  
1991 ◽  
Vol 25 (12) ◽  
pp. 1379-1383 ◽  
Author(s):  
Ossy J. Kasilo ◽  
Charles F.B. Nhachi
Keyword(s):  
Health Professionals ◽  
Information Service ◽  
Developed Countries ◽  
World Health ◽  
Teaching Institution ◽  
National Drug ◽  
Information Center ◽  
Drug Policies ◽  
Teaching Curriculum ◽  
Health Organization

The purpose of this work was to formulate guidelines to help health professionals in establishing or strengthening the capabilities of drug and toxicology information centers and related facilities in developing countries. These guidelines are based on the experience of an established drug and toxicology information service in Zimbabwe which has been operating for more than ten years and on information obtained from other centers in developed countries. The guidelines provide advice rather than a unique model and should therefore be adapted rather than adopted. We conclude that national drug policies should include provision for establishing drug information centers. The World Health Organization and similar organizations should assist in establishing these centers. We believe that a drug and toxicology information center is more beneficial to the community when it is part of the teaching curriculum and continuing education for health professionals. Therefore, the center should be located in a medical teaching institution.

Sign in / Sign up

Export Citation Format

Share Document